[Treatment of multiple sclerosis with intravenous hydrocortisone hemisuccinate in combination with cyclophosphamide or cytosine arabinoside].
D000328:Adult; D000906:Antibodies / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage* / Q000627:therapeutic use; D007275:Injections, Intravenous; D008297:Male; D008457:Measles / Q000276:immunology; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*
D000906:Antibodies; D003561:Cytarabine; D003520:Cyclophosphamide; D006854:Hydrocortisone
Wstepna próba leczenia chorych na stwardnienie rozsiane dozylnymi wstrzyknieciami hemibursztynianu hydrokortyzonu skojarzonego z cyklofosfamidem lub arabinozydem cytozyny